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BIOMEDICAL OPTICS
OCT sees the human retina sharply 
with adaptive optics
In vivo cellular visualization of the 
human retina at micrometer-scale 
resolution is possible by enhancing 
Fourier-domain optical-coherence 
tomography with adaptive optics, 
which compensate for the eye’s 
optical aberrations.
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Optical-coherence tomography (OCT) 
recently has gained widespread 
popularity among ophthalmologists for 
use in the clinical diagnosis and 
monitoring of human retinal disease. 
The key to this success is the 
ability of OCT to make noninvasive, 
in vivo measurements of the thickness 
of specific retinal layers--such as 
the nerve-fiber layer, which thins in 
patients with glaucoma. Current 
commercial OCT instruments use a 
“time-domain” approach in which 
coherent interference between light 
from the retina and a uniform 
reference sample is used to measure 
the reflectance of retinal tissue in 
a series of axial depth locations—
called an “A-scan.” Multiple A-scans 
are then obtained at a sequence of 
lateral locations, called a “B-scan,” 
in order to produce a 2-D image 
“slice” of the retina. These image 
slices can be collected at multiple 
locations throughout a subject’s eye 
to provide an assessment of the 
overall health of retinal structures.
Fourier-domain OCT
A new method called Fourier-domain 
OCT (FD-OCT) has recently 
demonstrated performance enhancements 
compared to the time-domain OCT 
imaging technique. Fourier-domain OCT 
offers a significant advantage in 
sensitivity and acquisition speed.1
Its differentiating feature is that 
data on the reflectance of the 
retinal tissue at each axial depth 
location is obtained simultaneously 
by recording the wavelength spectrum 
of the coherent interference between 
light reflected from the retina and 
the reference sample. This spectrum 
contains information about the 
reflectivity at each axial depth, 
which can be recovered by computing 
the inverse Fourier transform of the 
spectrum. Although the FD-OCT is an 
advance over the standard time-domain 
approach, the ability to visualize 
clinically important structures in 
the eye is still limited in both 
methods by their image resolution.
The resolution of OCT systems in 
the axial dimension is set by the 
coherence properties of the light 
source. Current light sources can 
provide axial resolution below 3 µm, 
which is more than sufficient to 
resolve the axial dimensions of most 
retinal cells.2 The lateral 
resolution is set by the diffraction 
limit of the pupil of the subject’s 
eye. For most subjects, the pupil can 
be dilated to at least 6 mm using 
standard pharmaceuticals, giving a 
diffraction-limited resolution of 
less than 3 µm. In practice, however, 
the lateral resolution is 
substantially degraded from the 
diffraction limit by the optical 
aberrations present in the eye. 
Consequently, most ophthalmic OCT 
systems are currently designed to be 
operated with a lateral resolution in 
the range of 15 to 20 µm. A 
resolution insufficient to allow 
visualization of many clinically 
important retinal cells, such as the 
cone photoreceptors, which are 
damaged in many retinal diseases, 
such as diabetic retinopathy and age-
related macular degeneration—two 
leading causes of blindness in 
developed countries.
OCT using adaptive optics
The solution for improving lateral 
resolution in ophthalmic OCT imaging 
is the use of adaptive optics (AO) to 
correct the aberrations in the eye. 
Adaptive optics work by measuring 
aberrations using a wavefront sensor 
(for example, a Shack-Hartmann 
sensor) and applying this information 
to the control of a deformable mirror 
in a closed loop, thereby 
compensating for the measured 
aberrations. This approach to 
improving the lateral resolution has 
previously been demonstrated in other 
retinal-imaging modalities, first in 
digital fundus cameras and more 
recently in scanning laser 
ophthalmoscopes.3, 4 For these 
instruments, the use of AO has been 
shown to produce retinal imagery at 
or near the diffraction limit (see 
www.laserfocusworld.com/articles/2411
42).
Capitalizing on the demonstrated 
success of AO to correct ocular 
aberrations, several groups have 
recently combined AO with OCT, 
seeking to produce the first 
capability for noninvasive, in vivo, 
3-D visualization of the human retina 
at the cellular level.5 Researchers 
at the University of California (UC) 
Davis Medical Center and the Lawrence 
Livermore National Laboratory (LLNL) 
have collaborated to develop one of 
these systems (see Fig. 1).
This instrument successfully 
combines the advantages of FD-OCT and 
advanced microtechnology for adaptive 
optics, using a 35-element bimorph 
deformable mirror (DM) built by 
AOptix Technologies (Campbell, CA) 
that was originally developed for use 
in wireless laser communications (see 
www.laserfocusworld.com/articles/2340
62). Use of this bimorph DM, which 
has a large range of surface 
deformation (up to ±16 µm) enables 
correction of up to ±3 diopters of 
defocus and enables the focal plane 
of the instrument, which has a depth 
of focus of about 60 µm, to be 
scanned axially through the retina to 
optimize the visualization of 
specific layers.
The AO system for the UC Davis-
LLNL instrument measures the 
aberrations in the subject’s eye 
using a fraction of the OCT imaging 
light reflected from the retina, 
which is directed into a Shack-
Hartmann wavefront sensor. This 
information is used to control the 
bimorph DM, thereby compensating for 
the measured aberrations. In one 
experimental example, the 
reconstructed RMS (root-mean-square) 
wavefront error was measured in a 
test subject before and during AO 
correction, together with the Zernike 
decompositions of the measured 
aberrations calculated (see Fig. 2). 
Results show that the AO system can 
effectively compensate low-order 
aberrations and maintain low RMS 
wavefront error during closed-loop 
operation.
Retinal images
The UC Davis-LLNL instrument has 
produced volumetric retinal images 
with 200 B-scans per volume and 500 
A-scans per B-scan (see Fig. 3). The 
A-scan exposure time was 50 µs, so 
the time needed to acquire the entire 
3-D image was approximately 5 
seconds. The images were acquired 
over a 0.5 ´ 0.2-mm rectangular area 
of retina with 1-µm lateral sampling 
density in both lateral directions. 
The light source was a 
superluminescent diode with a center 
wavelength of 841 nm and a spectral 
bandwidth of 50 nm, providing 6-µm 
axial resolution.
To evaluate the structures in 
different retinal layers, an average 
1-D power spectrum was calculated for 
the 200 B-scans in the 3-D volume 
images. A clear peak in the power 
spectrum was seen in the 
photoreceptor layer at the connecting 
cilia, due to regular structures (see 
Fig. 3, B-scan). The observed peaks 
in the spatial frequency correlate 
with cone-to-cone spacing observed in 
AO flood-illumination systems as well 
as that reported for cone-
photoreceptor mosaics studied by 
histology, conclusively demonstrating 
that the structures seen in the 
images in this layer are resolved 
photoreceptors.
Future work will include the use 
of an additional DM to better correct 
the higher-order aberrations and the 
development of image-processing and 
real-time retinal-tracking techniques 
to reduce artifacts due to eye 
motion. A detailed comparison of 
imagery obtained from AO FD-OCT, 
scanning-laser ophthalmoscopes and 
digital fundus photography using AO 
is also planned. But the preliminary 
results from AO-OCT systems are 
already demonstrating the promise of 
this ophthalmic-imaging modality for 
providing a new, clinically important 
view into the human eye.
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FIGURE 1. In the sample arm of an
adaptive-optics Fourier-domain 
optical-coherence-tomography (AO-FD-
OCT) instrument developed at UC Davis 
and LLNL, a series of afocal 
telescopes conjugates the pupil plane 
of the eye with key components of the 
system. (Key: γ is magnification; D 
is diameter; DM is the deformable 
mirror; M1 through M10 are spherical 
mirrors; P is the pupil plane; R is 
the retinal plane.)
FIGURE 2. Total RMS wavefront error 
before and during AO correction are 
compared (left). Reconstructed 
Zernike coefficients (right) are 
determined before (blue) and during 
(red) AO correction. Numbers 
correspond to the following Zernike 
coefficients: for second-order 
aberrations, 3 and 5 are astigmatism 
and 4 is defocus; for third-order 
aberrations, 6 and 9 are trefoil, and 
7 and 8 are coma; for fourth-order 
aberrations, 10 and 14 are tetrafoil, 
11 and 13 are second astigmatism, and 
12 is spherical aberrations; fifth-
order aberrations are 15 through 20.
FIGURE 3. A 3-D visualization (left) 
and a single B-scan (right) of 
microscopic retinal structure were 
obtained with AO FD-OCT. (Key: NFL is 
the nerve-fiber layer, IPL is the 
inner plexiform layer, OPL is the 
outer plexiform layer, ONL is the 
outer nuclear layer, CC is connecting 
cilia, RPE is retinal pigment 
epithelium.) The lateral structure 
seen in the CC layer is due to the 
individual cone photoreceptors that 
are resolved in this image with a 
measured spacing of 10 µm.
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